Eli Lilly's brand name for tirzepatide approved for type 2 diabetes. It contains the same active ingredient as Zepbound (which is the brand approved for weight management) — same molecule, different label and indication. People sometimes use Mounjaro off-label for weight loss, which has insurance and access implications.
Related terms: Tirzepatide · Zepbound · Ozempic · Off-label prescribing